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Other names: CKBBP1; RBX2; ROC2; SAG 




The gene encoding RNF7/SAG consists of four exons  
and three introns. 
Transcription 
About 0.8 kb mRNA with 342 bp open reading frame; 
three alternative splicing variants; induced by redox 
compound, tumor promoter (TPA), and hypoxia. 
Pseudogene 




A) Location. B) Local order. 











113 amino acids; 14 kDa protein; contains a RING 
domain (Cys-X2-Cys-X9-39-Cys-X1-3-His-X2-3-
Cys/His-X2-Cys-X4-48-Cys-X2-Cys) at the C-
terminus (50-102); Subjected to CK2 phosphorylation 
at Thr-10. 
Expression 
Ubiquitously expressed with the highest expression in 
heart, skeleton muscle, and testis in humans. 
Localisation 
Both cytoplasm and nucleus. 
Function 
1) In vitro test tube assays using purified protein 
showed that RNF7/SAG scavenges hydrogen peroxide 
at the expense of self oligomerization; has thiol-linked 
peroxidase activity; inhibits peroxynitrite-induced 
DNA damage. When complexed with the components 
of SCF E3 ubiquitin ligase, SAG has E3 ubiquitin 
ligase activity. 
2) In cultured cells, SAG over-expression inhibits 
apoptosis induced by redox, nitric oxide, 
ischemia/hypoxia, neurotoxin, MPP, and UV-
irradiation (unpublished data). SAG over-expression 
also promotes the S-phase entry and cell growth under 
serum starved conditions and inhibits TPA-induced 
neoplastic transformation. Silencing SAG expression 
by anti-sense or siRNA inhibits tumor cell growth, 
enhanced apoptosis induced by etoposide and TRAIL, 
and enhances TPA-induced neoplastic transformation. 
3) In whole animals, SAG over-expression via injection 
of SAG expressing recombinant adenovirus protects 
mouse brain tissues from ischemia/hypoxia-induced 
damage. Targeted expression of SAG in mouse skin 
inhibits tumor formation at the early stage, but 
enhances tumor growth at the later stage in a SAG-
transgenic DMBA-TPA carcinogenesis model. 
4) In yeast, SAG is a growth essential gene whose 
targeted deletion causes death, which can be rescued by 
human SAG. 
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Homology 
SAG is an evolutionarily conserved gene with 96% 
protein sequence identity between human and mouse, 
70% identify between human and C-elegans and 50% 
between human and yeast. Two family members are 
found in human and mouse, four in Drosophila, three in 







Lung and colon cancer 
Disease 
SAG/RNF7 over-expression was found in lung cancer 
and a subset of colon cancer tissues. 
Prognosis 
Lung cancer patients with SAG/RNF7 over-expression 
have a worse prognosis. 
Oncogenesis 
Targeted over-expression of SAG/RNF7 in mouse skin 
by K14 promoter inhibits tumor formation, but 
enhances tumor growth in DMBA-TPA-induced skin 
carcinogenesis.  
References 
Duan H, Wang Y, Aviram M, Swaroop M, Loo JA, Bian J, Tian 
Y, Mueller T, Bisgaier CL, Sun, Y. SAG, a novel zinc RING 
finger protein that protects cells from apoptosis induced by 
redox agents. Mol Cell Biol 1999;19:3145-3155. 
Sun Y. Alteration of SAG mRNA in human cancer cell lines: 
Requirement for the RING finger domain for apoptosis 
protection. Carcinogenesis 1999;20:1899-1903. 
Swaroop M, Bian J, Aviram M, Duan H, Bisgaier CL, Loo JA, 
Sun Y. Expression, purification, and biochemical 
characterization of SAG, a RING finger redox sensitive protein. 
Free Radicals Biol Med 1999;27:193-202. 
Swaroop M, Wang Y, Miller P, Duan H, Jatkoe T, Madore SJ, 
Sun Y. Yeast homolog of human SAG/ROC2/Rbx2/Hrt2 is 
essential for cell growth, but not for germination: Chip profiling 
implicates its role in cell cycle regulation. Oncogene 
2000;19:2855-2866. 
Duan H, Tsvetkov LM, Liu Y, Song Y, Swaroop M, Wen R, 
Kung HF, Zhang H, Sun Y. Promotion of S-phase entry and 
cell growth under serum starvation by SAG/ROC2/Rbx2/Hrt2, 
an E3 ubiquitin ligase component: association with inhibition of 
p27 accumulation. Mol Carcinog 2001;30(1):37-46. 
Huang Y, Duan H, Sun Y. Elevated expression of 
SAG/ROC2/Rbx2/Hrt2 in human colon carcinomas: SAG does 
not induce neoplastic transformation, but its antisense 
transfection inhibits tumor cell growth. Mol Carcinog 
2001;30:62-70. 
Sasaki H, Yukiue H, Kobayashi Y, Moriyama S, Nakashima Y, 
Kaji M, Fukai I, Kiriyama M, Yamakawa Y, Fujii Y. Expression 
of the sensitive to apoptosis gene, SAG, as a prognostic 
marker in nonsmall cell lung cancer. Int J Cancer 
2001;95(6):375-377. 
Sun Y, Tan M, Duan H, Swaroop M. SAG/ROC/Rbx/Hrt, a zinc 
RING finger gene family: molecular cloning, biochemical 
properties, and biological functions. Antioxid Redox Signal 
2001;3(4):635-650. (Review). 
Swaroop M, Gosink M, Sun Y. SAG/ROC2/Rbx2/Hrt2, a 
component of SCF E3 ubiquitin ligase: genomic structure, a 
splicing variant, and two family pseudogenes. DNA Cell Biol 
2001;20(7):425-434. 
Yang GY, Pang L, Ge HL, Tan M, Ye W, Liu XH, Huang FP, 
Wu DC, Che XM, Song Y, Wen R, Sun Y. Attenuation of 
ischemia-induced mouse brain injury by SAG, a redox- 
inducible antioxidant protein. J Cereb Blood Flow Metab 
2001;21(6):722-733. 
Kim SY, Bae YS, Park JW. Thio-linked peroxidase activity of 
human sensitive to apoptosis gene (SAG) protein. Free Radic 
Res 2002;36:73-78. 
Chanalaris A, Sun Y, Latchman DS, Stephanou A. SAG 
attenuates apoptotic cell death caused by simulated 
ischaemia/reoxygenation in rat cardiomyocytes. J Mol Cell 
Cardiol 2003;35(3):257-264. 
Kim SY, Lee JH, Yang ES, Kil IS, Bae YS. Human sensitive to 
apoptosis gene protein inhibits peroxynitrite-induced DNA 
damage. Biochem Biophys Res Commun 2003;301:671-674. 
Kim YS, Lee JY, Son MY, Park W, Bae YS. Phosphorylation of 
threonine-10 on CKBBP1/SAG/ROC2/Rbx2 by protein kinase 
CKII promotes the degradation of IkBa and p27kip1. J Biol 
Chem 2003;278:28462-28469. 
Tan M, Gallegos JR, Gu Q, Huang Y, Li J, Jin Y, Lu H, Sun Y. 
SAG/ROC-SCFbeta-TrCP E3 ubiquitin ligase promotes pro-
caspase-3 degradation as a mechanism of apoptosis 
protection. Neoplasia 2006;8(12):1042-1054. 
Yang ES, Park JW. Regulation of nitric oxide-induced 
apoptosis by sensitive to apoptosis gene protein. Free Radic 
Res 2006;40(3):279-284. 
Gu Q, Bowden, T.G., Normolle, D., and Sun, Y. SAG/ROC2 E3 
ligase regulates skin carcinogenesis by stage dependent 
targeting of c-Jun/AP1 and IkB/NF-kB. J Cell Biol 
2007;178:1009-1023. 
Gu Q, Tan M, Sun Y. SAG/ROC2/Rbx2 is a novel activator 
protein-1 target that promotes c-Jun degradation and inhibits 
12-O-tetradecanoylphorbol-13-acetate-induced neoplastic 
transformation. Cancer Res 2007;67(8):3616-3625. 
He H, Tan M, Pamarthy D, Wang G, Ahmed K, Sun Y. CK2 
phosphorylation of SAG at Thr10 regulates SAG stability, but 
not its E3 ligase activity. Mol Cell Biochem 2007;295(1-2):179-
188. 
Kim SY, Kim MY, Mo JS, Park JW, Park HS. SAG protects 
human neuroblastoma SH-SY5Y cells against 1-methyl-4-
phenylpyridinium ion (MPP+)-induced cytotoxicity via the 
downregulation of ROS generation and JNK signaling. 
Neurosci Lett 2007;413(2):132-136. 
Tan M, Gu Q, He H, Pamarthy D, Semenza GL, Sun Y. 
SAG/ROC2/RBX2 is a HIF-1 target gene that promotes HIF-
1alpha ubiquitination and degradation. Oncogene 
2008;27(10):1404-1411. 
This article should be referenced as such: 
Sun Y. RNF7 (RING finger protein-7). Atlas Genet Cytogenet 
Oncol Haematol.2008;12(4):289-291.  
 
 
